ciclopirox has been researched along with Cancer of Prostate in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prostate cancer is the most common cancer in the Western world." | 1.46 | Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide. ( Messina, CS; Schmidt-Wolf, IG; Weiher, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Messina, CS | 1 |
| Weiher, H | 1 |
| Schmidt-Wolf, IG | 1 |
1 other study available for ciclopirox and Cancer of Prostate
| Article | Year |
|---|---|
Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ciclopirox; Drug Synergism; Ethacrynic Acid; Humans; | 2017 |